The envelope protein E1 of hog cholera virus (HCV) was isolated by immunoaffinity purification with monoclonal antibodies (MAbs) directed against HCV. E1 consisted of a doublet of glycoproteins which varied in size from 51K to 56K between the three strains tested. E1 contains major antigenic determinants of HCV which are conserved, and are involved in neutralization by MAbs. In infected ceils, E 1 was found always connected with a glycoprotein of 31K. When Nlinked glycans were removed, E1 had a polypeptide backbone of approximately 47K. After proteolytic cleavage of E1 with Staphylococcus protease V8 and after electrophoresis and electrotransfer, peptide fragments containing different antigenic domains of E1 were detected with MAbs directed against HCV.
Introduction
Hog cholera virus (HCV), bovine viral diarrhoea virus (BVDV), and border disease virus are small, enveloped and positive-stranded RNA viruses that belong to the family Togaviridae, genus pestivirus (Westaway et al., 1985 a) . Little is known about the nucleic acid replication and the structural and non-structural proteins of these viruses. At least three structural proteins are thought to be involved : two envelope glycoproteins with Mr values of 55 000 (55K) and 46000 (46K) and a non-glycosylated core protein with an Mr of 36000 (36K) were identified for HCV (Enzmann & Weiland, t978) . Similar proteins have been identified as structural proteins of BVDV (Matthaeus, 1979) . The three structural proteins of the pestiviruses have been tentatively named E1 (55K to 57K), E2 (44K to 46K), and C (34K to 36K) (Westaway et al., 1985 a) ; however, full evidence that these proteins are indeed the two envelope proteins and the one nucleocapsid protein has never been presented. Renard et al. (1985) and Collett et al. (1988a) characterized BVDV RNA and produced BVDVderived cDNA clones; a preliminary map of the genomic organization of BVDV has also been published (Collett et al., 1988 b) . This map clusters the coding sequences for three glycoproteins, gp42, gp25 and gp53, in a single region near the 5' end of the genome. A new nomenclature has been proposed (Collett et al., 1989) in which gp53 stands for the major glycoprotein E1 of the pestiviruses. Recently, Moormann et al. (1988) and Rfimenapf et al. (1989) identified the viral RNA of HCV and synthesized cDNA clones. Comparison of the genomes of BVDV and HCV indicates that these viruses are highly homologous (Moormann et al., 1990) .
One of our group recently described an abstract model which maps the spatial relationships of the epitopes defined by 13 monoclonal antibodies (MAbs) against HCV (Wensvoort, 1989) . The epitopes were grouped in four antigenic domains (A, B, C and D) . Since MAbs directed against domains A, B and C neutralized HCV, it is probable that they recognize an envelope component of HCV. In the present report, we describe the isolation of a glycoprotein that reacts with these MAbs and identify it as glycoprotein E 1. Furthermore, we produced polypeptide fragments of E1 on which we located some of the antigenic domains recognized by the MAbs directed against HCV.
Methods
Virus, cells and anti-HCV immunogtobulins. HCV strain Brescia was biologically cloned by a threefold endpoint dilution. The 'Chinese' strain oflapinized vaccine virus (strain C) was adapted to growth in cell culture (Terpstra et al., 1990) . HCV strain Alfort 187 was obtained from Dr B. Liess, Hanover, F.R.G. Viruses were grown in PK-15 cells (strains Brescia and Alfort 187) or SK-6 cells (C strain) in roller bottles (1750 cm 2) for 48 h, as described before (Wensvoort et al., 1988) . The cell culture supernatant was decanted and the cells were harvested by shaking with glass beads and suspended in 50 ml of TNE buffer (0-1 MTris-HC1, 0.01 M-NaC1, 0-001 M-EDTA, pH 7.4). Cell suspensions and supernatant were stored at -70 °C for gradient purification of virions; or cell suspensions were sonicated twice for 10 s, after which the nonionic detergent NP40 was added to a final concentration of 1% (w/v). Cell lysates were then left for 1 h at room temperature and clarified for 15 rain at 1000 g. The resulting supernatant was stored at -70 °C.
When needed, this supernatant was thawed and clarified again for 20 min at 100000 g before use in immunoaffinity purification. Material from uninfected cell cultures was obtained in the same way.
Hyperimmune polyclonal anti-HCV swine immunoglobulins (PAb) were induced in specific pathogen-free (SPF) pigs (Terpstra et al., 1984) and conjugated to horseradish peroxidase (HRPO), according to the method of Wilson & Nakane (1978) . Negative control sera were collected from two 10-week-old SPF pigs. The pigs were then inoculated intranasaUy with 105 TCID5o of the HCV strain Brescia and blood samples were collected 5 weeks later to obtain early anti-HCV sera. Thirteen MAbs (MAbs l to 13) against HCV strain Brescia and HRPO conjugates of these MAbs were produced as described before (Wensvoort, 1986) . Epitopes of these MAbs were mapped in an abstract model consisting of four antigenic domains: A, B, C and D. Domain A was divided into three subdomains. MAbs 2, 3, 4 and 7 define subdomain A1 ; MAbs 9, 10 and 11 define subdomain A2; MAb 12 defines subdomain A3; MAb 6 defines domain B; MAbs 1, 5 and 8 define domain C; MAb 13 defines domain D. All MAbs are of the IgG isotype, and MAbs 1 to 8 neutralize HCV strain Brescia (Wensvoort, 1989) . MAbs and conjugates were stored in 50~ glycerol at -20 °C at a protein concentration of 4 mg/ml.
Immunoaffinity purification of HCV antigen from infected cells. MAbs 2, 3, 6 and 8 from hybridomas CVI- were purified from ascitic fluid by the method of Ey et aL (1978) .
Specific immunoglobulin-containing fractions were separated on a Protein A-Sepharose 48 (Pharmacia) column and dialysed against 0.1 M-bicarbonate buffer pH 8.3, containing 0.5 M-NaC1. Approximately 5 mg of the purified MAb was coupled per ml of CNBr-activated Sepharose 4B (Pharmacia), according to the manufacturer's instructions. The MAb-coupled beads were washed with all buffers that were appropriate for subsequent washing and elution procedures. One ml of the swollen beads was mixed with 100 ml of NP40-treated supernatant of HCV-infected cell lysates; another ml was mixed with supernatant from mock-infected cell lysates. The mixtures were incubated for 16 h at 4 °C on a rocking device. Beads were packed on a column and subsequently washed with 10 ml TNE plus 1% NP40, with 10 ml TNE plus 0-4 M-NaC1 plus 1% NP40, and with 10 ml TNE plus 0-1~ SDS plus 1 ~ NP40. Proteins that bound to the MAb were then eluted with 5 ~ (w/v) diethanolamine (Chong & Gillam, 1985) in 0.15 M-NaC1 plus 1 ~ NP40. The flow rate was 30 ml/h, and 0.5 ml fractions were collected during the entire washing and elution procedures. The presence of HCV-specific antigen was determined in an antigen capture assay (ACA), as described below. Positive and negative control fractions were subjected to electrophoresis or were dialysed overnight against distilled water, lyophilized in a Speed Vac Concentrator (New Brunswick Scientific), and stored at -20 °C for further use. HCV strain Brescia was purified with MAbs 2, 3, 6 and 8; strain Alfort 187 and strain C were purified with MAb 3.
Gradient purification ofHCV. HCV strain Brescia was purified from the cell culture supernatant or from infected cells which had been frozen and thawed and suspended in TNE. Virus in supernatant or suspension was first concentrated by precipitation with 7~ polyethylene glycol (PEG) (20 000) overnight at 4 °C. Pellets were resuspended in TNE buffer, layered on a 30 to 0 H glycerol, 0 to 55~ sodium potassium tartrate gradient (Purchio et al., 1984) , and centrifuged for 18 h at 26000 r.p.m, in a Beckman SW27 rotor at 4 °C. One ml fractions were collected and assayed for density and infectivity, and also examined in an ACA. Peak fractions were dialysed overnight at 4 °C against TNE. After NP40 had been added to a final concentration of 1 ~, HCV antigen in the fractions was isolated by immunoaflinity, as described above, and assayed by SDS-PAGE, electroblotting, and staining for glycoproteins with concanavalin A (Con A), as described below.
Identification of the HCV antigen in column fractions. The HCV Brescia antigen was detected in the eluates with an ACA, performed as described earlier (Wensvoort, 1989) , with MAb 6 as the capture antibody and MAb 2 as the HRPO conjugate. Fractions were diluted 1:100 in TNE plus 1 ~ NP40. Peak fractions that were ACA-positive were retested with MAb 6 as the capture antibody and the other MAbs were used independently as the HRPO conjugate to assess whether all 13 MAbs still recognized their epitope on the eluted material. Because strains Alfort 187 and C are not recognized by MAbs 6 or 8 , instead of the ACA, we used a different test to identify HCV antigen-positive fractions of these strains. Wells in ELISA plates (Costar EIA 3590) were incubated for 1 h at 37 °C with 100 ~tl of all fractions, which were diluted 1:10 in 50 mM-NaHCO3, pH 9.6. Plates were then washed and incubated for 1 h at 37 °C with an appropriate dilution of MAb 3 conjugated to HRPO. Plates were then washed and bound conjugate was detected as described for the ACA by incubation with tetramethylbenzidine (Sigma) and H202.
Polyacrylamide gel etectrophoresis. SDS PAGE was peformed in a discontinuous gel buffer system, as described by Laemmli (1970) . The acrylamide concentration was 4~ in the stacking gel and 10~ or 12~ in the separating gel. Immediately before electrophoresis, samples were dissolved in 0-125 M-Tris pH 6.8, 2.3 ~ SDS, and 0.001 ~ bromophenol blue (sample buffer, SB) with or without 5 % 2-mercaptoethanol and incubated at 100 °C for 3 rain. Prestained Mr standards (Bethesda Research Laboratories) used as marker proteins were: myosin, 200K; phosphorylase B, 97K; bovine serum albumin, 68K; ovalbumin, 43K; ct-chymotrypsin, 25K; fl-lactoglobulin, 18K; lysozyme, 14K. Proteins in the gel were detected by staining with Coomassie blue (CBB) or with the silver stain technique (Oakley et al., 1980) . Glycoproteins in the gel were detected by periodate-Schiff's staining (PAS) Zacharias & ZeU, 1969) .
For two-dimensional electrophoresis, samples were dissolved in SB, incubated at 56 °C for 30 min, loaded in wide slots, and subjected to electrophoresis. The gel was cut vertically in strips for use in electroblotting or were incubated for 30 min at 56 °C in SB and 5~ 2-mercaptoethanol, loaded horizontally on a second gel, and subjected to electrophoresis in the second dimension.
Transfer of proteins to nitrocellulose membranes. Electroblotting was performed as described by Towbin et al. (1979) . Gels were soaked for 30 min in transfer buffer (25 mM-Tris-HC1 pH 8-3, 0.1~ SDS, 20~ methanol), and proteins were electrophoretically transferred to nitrocellulose paper (0.45 ~tm, Schleicher & Schfill) for 16 h at 30 V and room temperature. After transfer, nitrocellulose membranes (blots) were stored in phcsphate-buffered saline (PBS) at 4 °C, or rinsed in demineralized water and stored dry at -20 °C.
Glycoproteins on blots were detected by staining with Con A and HRPO, as described by Hawkes (1982) . Con A-HRPO complexes were detected by incubating the blots in a freshly prepared 0.06~ (w/v) solution of 4-chloro-l-naphthol (Sigma) in 10 ml of methanol, 40 ml of distilled water, and 15 pl of 30~ H202.
Proteins were detected immunologically by preincubating the blots for 30 rain at 37 °C in PBS plus 0.85 M-NaCI plus 0.05~ Tween 80 and 5 ~ horse serum, and then incubating them for 1 h at 37 °C with the MAb-HRPO and PAb-HRPO conjugates diluted in the same buffer. Alternatively, preincubated blots were incubated for 1 h at 37 °C with 1:10 dilutions of either pig sera or rabbit sera, washed, and incubated with either a mixture of MAb HRPO conjugates directed against porcine IgM and IgG (Van Zaane & Hulst, 1987) or with an HRPO conjugate directed against rabbit IgG and IgM (Pasteur Institute). Some blots were examined for the presence of murine immunoglobulin heavy and light chains by incubating them as above with an HRPO conjugate directed against murine IgG (heavy and light) (Pasteur). Blots were then washed in PBS and incubated in substrate solution, as described above.
Preparation of antibodies in rabbits.
Lyophilized peak fractions of immunoaffinity-purified HCV Brescia were each reconstituted with 0-5 ml distilled water, and then mixed with equal volumes of Freund's complete adjuvant. Four rabbits were inoculated intramuscularly with approximately 100 ng of the HCV Brescia antigen. Four weeks later the rabbits were inoculated again with a mixture of the HCV Brescia antigen and Freund's incomplete adjuvant. Two weeks later the rabbits were inoculated again intravenously with 105 TCID50 of the C strain virus. Serum samples were collected at 0, 6 and 9 weeks after the first inoculation.
Deglycosylation and proteolytic cleavage studies. Lyophilized peak fractions of immunoaffinity-purified HCV Brescia were each reconstituted with 0.5 ml distilled water. For the deglycosylation studies, fractions of 200 tal were mixed with 0.2 units of an endoglycosidase F/glycopeptidase F preparation (Boehringer Mannheim) in 100 ptl of distilled water and 100 ~tl of PBS pH 7, 1 ~ NP40. Control fractions were incubated similarly with the same buffer, but without the enzymes. After incubation of the preparations for 18 h at 37 °C, the samples were mixed with SB containing 5~ 2-mercaptoethanol, and heated for 3 rain at 100 °C. Samples were then analysed by SDS-PAGE, transferred to nitrocellulose paper, and stained with Con A and HRPO or immunostained with HRPO conjugates of MAbs 1 to 8, as described above.
For the protease V8 studies, reconstituted peak fractions were subjected to SDS-PAGE under reducing conditions. Gels were stained with CBB, as described above. After destaining, gel pieces (4 × 8 ram) which contained glycoprotein (gp54-gp51) doublets were excised from the gel. The position of the top band was marked by cutting a small comer offthe gel piece. The gel pieces were immersed in SB containing 5 ~ 2-mercaptoethanol, incubated for 30 min at 56 °C, and mounted in slots of a 1.5 mm thick polyacrylamide gel, prepared with 4~ acrylamide in the 5 cm long stacking gel and 15 ~ polyacrylamide in the separating gel. Care was taken to mount each piece with the top band at the left-hand side of the slot. The doublet was then cleaved with protease V8 (Sigma), as described by Cleveland et aL (1977) . Briefly, the pieces were overlaid with 20 ~tl of SB containing 5~ 2-mercaptoethanol, and with 10 pl 0.125 M-Tris-HC1 pH 6.8, 10~ glycerol, 0.25 ~ protease V8. Electrophoresis was then performed in the normal manner, except that the current was turned offfor 30 min when the bromophenol blue dye approached the bottom of the stacking gel. After electrophoresis, polypeptides were transferred to nitrocellulose paper and stained with Con A and HRPO or immunostained with HRPO conjugates of MAbs 1 to 8, as described above.
Results

Immunoaffinity purification
CNBr-activated Sepharose 4B beads coupled with MAb 2 were incubated with lysates of Brescia-infected or mock-infected cells. Beads were packed on a column, washed with several buffers, and eluted with 5~ diethanolamine. All fractions were collected and tested in an ACA. All fractions derived from the mock-infected cell lysate scored negative [optical density (O.D.) < 0.100]. The Brescia-positive cell lysate yielded two peaks: a minor peak (O.D. approximately 0.6) appeared after the column was washed with buffer containing SDS; the major peak (O.D. > 2) appeared after elution with diethanolamine. All fractions (52 to 60) of this peak (Fig. 1, top) were retested in ACAs using MAb 6 as the capture antibody and all other MAbs individually as the HRPO conjugate. The same peak was detected in all tests, with fractions 53 to 56 giving the highest signals (data not shown). Thus we concluded that the peak fractions contained a specific antigen which bound to each of the 13 MAbs. Fractions 52 to 60 and corresponding fractions from the mock-infected cells were then treated with SB containing 2-mercaptoethanol, analysed by SDS-PAGE, and stained (Fig. 1, bottom) . A 42K protein was detected in both negative and positive lysates. Three proteins of 54K, 51K and 31K were detected only in the ACA-positive fractions. Subsequent PAS staining (data not shown) revealed that these proteins were glycoproteins. The non-specific 42K band was not detected by PAS staining.
Samples of positive and negative fraction 54 were treated with SB or with SB that contained 2-mercaptoethanol and analysed by SDS-PAGE and immunoblotting. A complex pattern of bands was found when non-reduced samples were analysed in SDS-PAGE (Fig.  2a) . After silver staining, two diffuse but prominent bands of approximately 90K and 70K were revealed. Above these, some high Mr bands were detected. Three bands of 47K, 45K and 24K were barely visible. Immunoblotting revealed that the 45K, 47K, 70K, 90K and the high Mr bands were detected by all 13 MAbs and the polyclonal anti-HCV pig sera (results shown for MAb 8, Fig. 2a ). All these bands and the 24K band were positive after staining with Con A (Fig. 3) .
When reduced samples were analysed by SDS-PAGE (Fig. 2b) , silver staining confirmed the three HCVspecific and one non-specific protein bands that were detected earlier. After immunoblotting, gp54 and gp51 were detected by MAbs, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 11, by the anti-HCV pig sera, by two of the four rabbit sera collected at week 6, and by all four rabbit sera collected at week 9 after inoculation with the immunoaffinitypurified HCV Brescia antigen (results shown for MAb 8, Fig. 2 ). Gp54, gp51 and gp31 were detected by staining with Con A (Fig. 3) . The HCV-negative pig sera and the preinoculation rabbit sera did not stain any protein bands in immunoblotting. Exactly the same pattern of bands were detected when the Brescia virus was purified with MAbs 3, 6 and 8. Similar glycoproteins were detected by immunoaffinity purification of cells infected with strain Alfort 187 and strain C (Fig. 4) . Under reducing conditions, gp31 and a glycoprotein doublet which bound to MAb 3 were isolated from all three viruses. The glycoprotein doublet of strain C had a slightly higher Mr (56K to 53K) than that of strains Brescia and Alfort 187. Under nonreducing conditions, heteromeric complexes similar to Fig. 1 ), obtained by immunoaffinity purification from HCV-negative ( -) and HCV-positive ( + ) cell lysates were analysed under non-reducing (a) and reducing (b) conditions by SDS-PAGE on a 12~ polyacrylamide gel and stained by silver stain (gel), or transferred to nitrocellulose and immunostained (blot), M, Mr markers. HCV-specific bands are indicated by arrowheads. Under non-reducing circumstances HCV proteins were found at 24K, 45K, 47K, 70K, 90K, and at higher Mr values (h). MAbs 1 to 13 and three pig sera against HCV detected all but the 24K band (results shown for MAb 8). Under reducing conditions, three bands at 31K, 51K and 54K were found. MAbs 1 to 9 and 11, three pig sera and six rabbit sera against HCV detected the bands at 51K and 54K (results shown for MAb 8).
those in strain Brescia were detected in strain Alfort 187 and strain C (results not shown).
Under non-reducing conditions, most of the virus antigen was detected as heteromeric complexes of 70K, 90K and higher. Occasionally, similar complexes were detected when overloads of reduced antigen were Sepharose 4B beads that had been coupled with MAb 2. Material that was specifically bound to the MAb was eluted with 5 ~ diethanolamine starting at fraction 52. Top : the eluate was tested in an ACA to detect HCV antigen; MAb 6 was used as the capture antibody and MAb 8 as the HRPO conjugate. Bottom: peak fractions were analysed by SDS PAGE on a 10% polyacrylamide gel, and were stained with CBB; M, Mr markers. Fig. 3 . Two-dimensional electrophoresis. Material from HCV-positive fractions 54, 55 and 56 (see Fig. 1 ), was pooled and analysed under non-reducing conditions (first dimension) in SDS-PAGE on a 12 ~ polyacrylamide gel. Vertical strips were cut from the gel and either transferred to nitrocellulose and stained for glycoproteins with Con A (top), or loaded horizontally onto a second 12~ polyacrylamide gel, and subjected to electrophoresis, together with a new sample of the pooled fractions (left), under reducing conditions (second dimension). After transfer to nitrocellulose, staining was done for glycoproteins as above. HCV-specific bands are indicated by arrows.
analysed in SDS-PAGE, indicating that disulphide bridges re-formed under these circumstances. The effect of disrupting these disulphide bridges was studied by two-dimensional electrophoresis, in which a gel slice containing the full pattern of non-reduced complexes of the HCV Brescia antigen was analysed in the second dimension under reducing conditions. After transfer of the proteins to nitrocellulose, the distribution of the glycoproteins was studied by staining with Con A (Fig.  3) . The apparent Mr of gp24 and of the doublet gp47-gp45 did change after reduction, indicating that the migratory pattern in SDS-PAGE had changed, possibly due to a greater unfolding of the proteins. The bands comigrated with the protein bands of the reduced control sample, showing that gp24 became gp31 and that gp47-gp45 became gp54-gp51. Gp70 resolved completely into gp31 and the doublet, as did most of the high Mr bands. Gp90, however, resolved into a diffuse band at 70K to 76K and into the gp54-gp51 doublet and gp31. Therefore, gp70 comprises heterodimers made up of gp31 and one member of the gp54-gp51 doublet. Gp90 probably comprises heterotrimers made up of two copies of gp31 and one member of the doublet. To determine whether the gp54-gp51 doublet and gp31 were structural proteins, we isolated these proteins from the gradient-purified HCV strain Brescia. Initially, HCV was gradient-purified from infected cell supernatants. One ml fractions were collected, tested for infectivity and density, and analysed in the ACA. The highest infectivity titres and highest ACA signals were detected in one peak with densities at 1-13 to 1-15 g/ml (results not shown). After this peak was purified by immunoaffinity with MAb 3 and then assayed by SDS-PAGE, we detected only gp54 and gp51. However, as the amount of protein purified was very small, we could not validate the conclusion that gp31 was absent from this . HCV antigens from these viruses were purified as shown in Fig. 1 with MAb 3 bound to CNBr-activated Sepharose 4B. Eluted material was analysed by SDS-PAGE under reducing conditions on a 12% polyacrylamide gel. Proteins were transferred to nitrocellulose paper, and blots were stained for glycoproteins with Con A (left) or immunostained with MAb 3 (right).
peak. Gradient purification of strain Brescia from infected cell lysates resulted in fractions with highest infectivity titres at densities of 1.13 to 1.15 g/ml and highest ACA signals at densities of 1.12 to 1.14 g/ml (Fig.  5) . The seven individual fractions constituting the two peaks were purified by immunoaffinity and then assayed in SDS-PAGE under reducing conditions. Proteins were then electroblotted and stained with Con A to detect glycoproteins (Fig. 6 ). In the first three fractions, which corresponded with the infectivity peak, gp54 and gp51 were prominent, but gp31 was barely visible. The fractions that had high ACA signals but low infectivity clearly contained gp31.
Proteolytic cleavage studies
The immunoaffinity-purified HCV Brescia antigen was deglycosylated, or left untreated, and analysed under reducing conditions in SDS-PAGE. Staining of the gels with CBB revealed that deglycosylation resulted in two HCV-specific polypeptides of 47K and 25K (results not shown). After transfer to nitrocellulose, polypeptides were stained with Con A and HRPO to detect glycoproteins and also stained with HRPO conjugates of MAbs 1 to 8. Glycoproteins which bound to Con A were not detected in enzyme-treated samples, whereas MAbs 1 to 8 all detected a single band of 47K (Fig. 7) . For protease V8 studies, gel slices containing gp54-gp51 were mounted in the slots of a polyacrylamide gel and subjected to limited proteolysis with protease V8. After electrophoresis, polypeptide fragments were transferred to nitrocellulose paper. Staining with Con A (Fig.  8) revealed that gp54-gp51 had been digested into five fragments of 42K to 39K, 35K to 32K, 31K, 27K to 24K and 19K. Testing gel pieces containing only the gp54 or the gp51 band (results not shown) revealed that gp54 yielded five fragments of 42K, 35K, 31K, 27K and 19K, and that gp51 yielded five fragments of 39K, 32K, 31K, 24K and 19K, after being digested with protease V8. HRPO conjugates of MAbs 2, 3, 4 and 7 stained all fragments except those of 19K. Conjugates of MAbs 1, 5, 8 and 6 stained only the 35K-32K pair (results shown for MAb 3 and MAb 8 in Fig. 8 ).
D i s c u s s i o n
MAbs which were specific for HCV but did not react with BVDV were used to purify proteins by immunoaffinity from cell lysates infected with the HCV strain Brescia. Three HCV-specific glycoproteins of 54K, 51K and 31K were detected by SDS-PAGE under reducing conditions. Under nonreducing conditions, heteromeric forms of 70K, 90K and higher were detected. Gp54 and gp51, but not gp31, were detected by immunoblotting with the 13 MAb-HRPO and PAb-HRPO conjugates, and with HCV-specific pig and rabbit sera. In a previous report (Wensvoort, 1989) it was demonstrated that the 13 MAbs defined four antigenic domains: A, B (MAb 6), C (MAbs 1, 5 and 8) and D (MAb 13). Domain A was divided into A1 (MAbs 2, 3, 4 and 7), A2 (MAbs 9, 10 and 11) and A3 (MAb 12). Domains A1 and A2 were conserved among HCV strains, and domains A1, B and C were involved in neutralization. We now conclude that these domains are located on gp54 and on gp51.
Deglycosylating the gp54-gp51 doublet by treating it with endoglycosidase F and glycopeptidase F resulted in 5 ). The HCV antigen was analysed by SDS-PAGE under reducing conditions on a 12~ polyacrylamide gel. Proteins were transferred to nitrocellulose paper, and blots were stained for glycoproteins with Con A. El, envelope protein 1; gp31, glycoprotein with apparent Mr of 31K.
one polypeptide fragment of 47K which was devoid of Con A-binding glycans. This finding implies that the doublet consists of a polypeptide chain of 47K to which several oligosaccharide chains, totalling 4K (gp51) to 7K (gp54), are attached. It is obvious that the polypeptide backbone is not always fully glycosylated, but assuming that N-linked glycans have an average M r of 2K to 3K, three to four glycans may be attached to a fully glycosylated protein. The above data agree with those of Donis & Dubovi (1987) , who demonstrated that deglyco- Fig. 7 . Deglycosylation of E1 and gp31. Samples of E1 gp31 complexes were deglycosylated as described in the text (lanes 3, 4, 7 and 8), or left untreated (lanes 1, Z 5 .and 6). After SDS-PAGE and electrotransfer to nitrocellulose paper, the resulting peptides were stained with Con A (lanes 1, 2, 3 and 4) or with MAb 3 (lanes 5, 6, 7 and 8).
sylation of gp56-gp58 of BVDV resulted in a single polypeptide of 52K, and who suggested that three to five glycans are attached to this polypeptide. MAbs 1 to 8 all reacted with the deglycosylated and reduced 47K polypeptide backbone of the protein. Therefore, binding of the neutralizing MAbs directed against domains AI, B and C, does not depend on glycosylation or on a fully native tertiary structure.
After gradient purification of HCV strain Brescia, the gp54-gp51 doublet was found to be associated with infectious virus, unlike gp3t, which was not. This finding suggests that the doublet, and not gp31, is a structural part of the virion. As the M r of the doublet corresponds with that of the E1 protein, as determined by Enzmann & Weiland (1978) , and because eight of the above 13 MAbs neutralize HCV strain Brescia, we conclude that the gp54-gp51 doublet is the envelope protein E1 of HCV strain Brescia. Protein E1 of strains Brescia and Alfort had identical M r values, but E1 of strain C had a slightly higher Mr. BVDV is reportedly neutralized by MAbs directed against a 53K to 55K glycoprotein (Magar et al., 1988) , against a heterogeneous 56K glycoprotein (Bolin et al., 1988) , and against a 56K to 58K glycoprotein (Donis et al., 1988) . Thus, we can safely conclude that E1 of the pestiviruses is heterogeneous, has an Mr of approximately 51K to 58K, and induces neutralizing antibodies. Envelope protein E1 would then be gp53, according to nomenclature based on the gene map of BVDV (Collett et al., 1989) . In an earlier paper, Collett et al. (1988a) demonstrated that gp53 of BVDV contains four potential N-linked glycosylation sites, a finding that agrees well with the 4K to 7K difference we observed between E1 and its deglycosylated backbone.
Purification of all three HCV strains revealed a new HCV-specific glycoprotein, designated gp31. Two-dimensional electrophoresis showed that, at least in cell lysates, E1 and gp31 were part of complex heteromers that fell apart when they were reduced. The exact nature of the bond between E 1 and gp31 remains unclear. The bond could be formed by disulphide bridges between the two proteins, but could also be caused by hydrophobic or other interactions between E1 and gp31 which can only occur when internal disulphide bridges are in place. Gp31 and heteromers have not been reported earlier.
Several investigators, however, have demonstrated a BVDV-specific glycoprotein of 23K to 25K (for review see Collett et al., 1989) . Using the predicted amino acid sequence of BVDV strain NADL, Collett et al. (1988b) demonstrated that gp25 is a hydrophobic polypeptide containing two potential N-linked glycosylation sites and several cysteines. In our immunoblotting tests, gp31 was not detected by any of the anti-HCV pig sera nor by any of the rabbit sera raised against El-gp31 complexes. Thus, either gp31 is not very antigenic, or antibody binding to gp31 depends heavily on the tertiary structure of the protein and is impossible after the protein has been subjected to SDS-PAGE. Since we found gp31 only in HCV-infected cell lysates and not in infectious virus, this glycoprotein may be non-structural; or, similar to the pre-M protein of the Flaviviridae, it may be found only in immature virions (Westaway, 1985 b) . These speculations may be clarified when antibodies specific to gp31 are finally developed.
In a previous report (Wensvoort, 1989) , it was shown that the neutralizing MAbs 1 to 8 were directed against antigenic domains A1, B or C. The non-neutralizing MAbs 9 to 13 were directed against domains A2, A3 or D. The antigenic domains were topographically distinct in competitive binding and antigen capture studies. In the present study, we showed that the neutralizing MAbs reacted with reduced E1 in immunoblotting, whereas the other MAbs generally did not. We also demonstrated that E1 is not always fully glycosylated. Since there is a distinct (3K) difference between gp51 and gp54, we can assume that the polypeptide backbone of E1 contains a site X where an additional glycan can be attached. The proteolytic cleavage experiments of this study were designed to investigate where the important domains A 1, B and C and site X were located on El.
Cleaving E1 with protease V8 produced five glycanbearing fragments derived from gp54 and five derived from gp5 I. In addition to the original gp54-gp51 pair, we detected three pairs of fragments (of 42K to 39K, of 35K to 32K, and of 27K to 24K) which contained site X and two pairs (of 31K and of 19K) which were glycosylated but did not contain site X. All fragments except the 19K fragment contained domain A1, since they reacted with MAbs 2, 3, 4 and 7. Only the 35K to 32K fragment contained domains B and C, since it reacted with MAb 6 and with MAbs 1, 5 and 8. Therefore, domains B and C must be situated on that part of the 35K-32K fragment which did not overlap the other fragments, thus indicating that domains B and C are located at some distance from domain A1. Since we also detected an A1-positive fragment (31K) which did not contain site X, domains B and C are most likely to be separated from domain A1 by the part of E1 containing site X. When E1 was cleaved by trypsin or by CNBr (G. Wensvoort, unpublished data), results were found which corroborated, but did not refine further, the layout of the antigenic domains on El, as presented above.
Earlier (Wensvoort, 1989) , one of us demonstrated that mixtures of MAbs directed against domain A1 and against domains B or C had much higher titres in neutralization tests than expected. Mixtures of MAbs defining domains B and C did not have this synergistic effect. The synergism suggests that antibodies directed against E1 have two different mechanisms of neutralization: one mechanism shared by MAbs defining domains B and C, and another for MAbs defining domain A 1. This suggestion is supported by the results of the present study, which indicate that domains B and C are adjacent to each other but at a distance from domain A1.
In conclusion, we isolated two glycoproteins of HCV: E1 and gp31. E1 is an en#elope protein of HCV, on which major antigenic domains, A1, B and C, are located. A1 is conserved among all HCV strains, and A1, B and C elicit neutralizing antibodies, at least in mice. Gp31 is clearly less immunogenic. Specific antisera, possibly obtained from animals immunized with HCV cDNA expression products, are still needed in order to ascertain whether gp31 is encoded by the viral genome.
